Show results for
Refine by
Molecular Diagnostic Software In Usa
7 software items found
Manufactured by:Mammoth Biosciences, Inc. based inBrisbane, CALIFORNIA (USA)
The CRISPR-based detection platform: Our revolutionary method for molecular diagnostics, enabling limitless testing ...
by:BioDiscovery, A Bionano Genomics Company based inEl Segundo, CALIFORNIA (USA)
As described in Chaubey et al., Journal of Molecular Diagnostics, vol. 22, No. 6 June 2020, they used 10x WGS and validated that the NxClinical algorithm detected all CNVs and AOH that were found by high-resolution SNP arrays. Figure 2. shows a small exonic deletion detected using 10x WGS with the MSR algorithm. ...
Manufactured by:Mammoth Biosciences, Inc. based inBrisbane, CALIFORNIA (USA)
Discovering novel CRISPR systems: We are addressing the current challenges of CRISPR-Cas systems and expanding the scope of use by applying our proprietary discovery platform to identify novel Cas ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Clinical interpretation has been one of the most complex and time-consuming aspects of transforming genomic data into meaningful results, until ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Identifying patterns of genomic scarring in ovarian cancer samples. Accurate identification and reporting of Homologous Recombination Deficiency (HRD) status are critical for better patient management. SOPHiA DDM Dx HRD Solution is a CE-marked in vitro diagnostic (IVD) application leveraging low-pass Whole Genome Sequencing (WGS) and a proprietary deep-learning algorithm. Powered by the advanced ...
by:Orchard Software Corporation based inCarmel, INDIANA (USA)
Orchard’s Molecular solution includes dynamic workflow support that orchestrates the entire molecular testing process from pre-analytical through post-analytical. Our molecular support has been enhanced by the acquisition of Corwen, LLC and their PRSQRL solution, to help automate processes and reduce the workload burden on laboratory staff. ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Enabling novel fusion detection in small samples to improve lung cancer management. Sensitive novel fusion detection optimized for small lung cancer FFPE biopsies enhance patient care. SOPHiA DDM™ Dx RNAtarget Oncology Solution (ROS) is a CE-marked in vitro diagnostic (IVD) application based on next-generation sequencing (NGS) enabling accurate and sensitive detection of novel ...